Activation of the transcription factor nuclear factor-κB in human inflamed synovial tissue

Arthritis and Rheumatism

Volumn 39, Issue 4, 1996, Pages 583-591

  Marok, R ^a   Winyard, P G ^a   Coumbe, A ^a   Kus, M L ^a   Gaffney, K ^a   Blades, S ^a   Mapp, P I ^a   Morris, C J ^a   Blake, D R ^a   Kaltschmidt, C ^b   Baeuerle, P A ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; AUTOPSY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVITIS; TRANSCRIPTION REGULATION;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NF-KAPPA B; OSTEOARTHRITIS; SYNOVIAL MEMBRANE;

EID: 15844384253     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390407     Document Type: Article

References (36)

1. Baeuerle PA, Baltimore D: The physiology of the NF-κB transcription factor. In, The Hormonal Control of Gene Transcription. Edited by P Cohen, JG Foulkes. Amsterdam, Elsevier, 1991
2. Blake DR, Winyard PG, Marok R: The contribution of hypoxic-reperfusion injury to inflammatory synovitis: the influence of reactive oxygen intermediates on the transcriptional control of inflammation. Ann N Y Acad Sci 723:308-317, 1994
3. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle PA: Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature 365:182-185, 1993
4. Zabel U, Henkel T, Dos Santas Silva M, Baeuerle PA: Nuclear uptake and control of NF-κB by MAD-3, an IκB protein present in the nucleus. EMBO J 12:201-211, 1993
5. Traenckner EB-M, Wilk S, Baeuerle PA: A proteasome inhibitor prevents activation of NF-κB and stabilises a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J 13:5433-5441, 1994
6. Staal FJT, Roederer M, Herzenberg LA: Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A 87:9943-9947, 1990
7. Toledano MB, Leonard WJ: Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci U S A 88:4328-4332, 1991
8. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10:2247-2258, 1991
9. Schreck R, Grassman R, Fleckenstein B, Baeuerle PA: Antioxidants selectively suppress activation of NF-κB by human T-cell leukemia virus type 1 tax protein. J Virol 66:6288-6293, 1992
10. Liao F, Andalibi A, deBeer FC, Fogelman AM, Lusis AJ: Genetic control of inflammatory gene induction and NF-κB-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91:2572-2579, 1993
11. Kaltschmidt C, Kaltschmidt B, Lannes-Vieira J, Kreutzberg GW, Wekerle H, Baeuerle PA, Gehrmann J: Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis. J Neuroimmunol 55:99-106, 1994
12. Kopp E, Ghosh S: Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956-959, 1994
13. Weber C, Erl W, Pietsch A, Weber PC: Aspirin inhibits nuclear factor-κB mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 91:1914-1917, 1995
14. Kaltschmidt C, Kaltschmidt B, Henkel T, Stockinger H, Baeuerle PA: Selective recognition of the activated form of transcription factor NF-κB by a monoclonal antibody. Biol Chem Hoppe Seyler 376:9-16, 1995
15. Henkel T, Zabel U, van Zee K, Mueller JM, Fanning E, Baeuerle PA: Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit. Cell 68:1121-1133, 1992
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kapian SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 19°8
17. Hsu SU, Raine L, Fauger H: Use of avidin biotin peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 29:577-580, 1981
18. Shu S, Ju C, Fan L: The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 85:169-171, 1988
19. Rooney M, Condell D, Quinlan W, Daly L, Whelan A, Feighery C, Bresnihan B: Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis Rheum 31:956-963, 1988
20. Soden M, Rooney M, Cullen A, Whelan A, Feighery C, Bresnihan B: Immunohistochemical features in the synovium obtained from clinically uninvolved knee joints of patients with rheumatoid arthritis. Br J Rheumatol 28:287-292, 1989
21. Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA: Constitutive NF-κB activity in neurons. Mol Cell Biol 14:3981-3992, 1994
22. Frankenberger M, Pforte A, Sternsdorf T, Passlick B, Baeuerle PA, Zieglerheitbrock HWL: Constitutive NF-κB in cells of the monocytic lineage. Biochem J 304:87-94, 1994
23. Costello R, Cerdan C, Lipcey C, Algarte M, Martin Y, Baeuerle PA: The role of NF-κB1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules. Cell Growth Differ 4:947-954, 1993
24. Lernbecher T, Muller U, Wirth T: Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature 365:767-770, 1993
25. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D: Embryonic lethality and liver degeneration in mice lacking the Rel-A component of NF-κB. Nature 376:167-170, 1995
26. Weih F, Carrasco D, Durham SK, Rizzo C, Ryseck RF, Bravo R: Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of Rel-B, a member of the NF-κB/Rel family. Cell 80:331-340, 1995
27. Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D, Tizard R, Cate R, Lo D: Expression of rel-B is required for the development of thymic and dendritic cells. Nature 373:531-536, 1995
28. Sha WC, Liou HC, Tuomanen EI, Baltimore D: Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330, 1995
29. Headerson DRF, Jay son MIV, Tribe CR: Lack of correlation of synovial histology with joint damage in rheumatoid arthritis. Ann Rheum Dis 34:7-11, 1975
30. Bresnihan B: Synovial histology in rheumatoid arthritis: clues for the clinician. J Rheumatol 15:885-887, 1988
31. Yang JP, Merin JP, Nakano T, Kato T, Kitade Y, Okamoto T: Inhibition of the DNA-binding activity of NF-κB by gold compounds in vitro. FEBS Lett 361:89-96, 1995
32. Arend WP, Dayer J-M: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 38:151-160, 1995
33. Green JE, Hinrichs SH, Vogel J, Jay G: Exocrinopathy resembling Sjögren's syndrome in HTLV-I tax transgenic mice. Nature 341:72-74, 1989
34. Sumida T, Yonaha F, Maeda T, Kita Y, Iwamoto I, Koike T, Yoshida S: Expression of sequences homologous to HTLV-I tax gene in the labial salivary glands of Japanese patients with Sjögren's syndrome. Arthritis Rheum 37:545-550, 1994
35. Rothschild BM, Masi AT: Pathogenesis of rheumatoid arthritis: a vascular hypothesis. Semin Arthritis Rheum 12:11-31, 1992
36. Winyard PG, Tatzber F, Esterbauer H, Kus ML, Blake DR, Morris CJ: Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 52:677-680, 1993